Diet reversed diabetes in 46% of patients in the gold standard trial. Five years later, 13% held it. The honest answer to who needs GLP-1 drugs lives in that gap, and it’s more nuanced than either side wants to admit.
Semaglutide works. The trials don’t lie. But 45% of weight lost is muscle, two-thirds comes back within a year of stopping, and no long-term safety data past 10 years exists. Here’s what the research actually says.
I got curious about the Ozempic conversation and went down a research rabbit hole. Here’s what the drug actually does, where it came from, and what it’s officially supposed to be used for.
